Mirum Pharmaceuticals, Inc. (MIRM): Cash & Equivalents
$296.68M
As of 2025-12-31
$330.73M
As of 2026-06-30
+119.6%
3-year compound annual growth
+15.9%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $296.68M | +33.3% | 2026-02-25, Balance as of period end |
| 2024-12-31 | $222.50M | -22.3% | 2026-02-25, Balance as of period end |
| 2023-12-31 | $286.33M | +922.5% | 2025-02-26, Balance as of period end |
| 2022-12-31 | $28.00M | -10.6% | 2024-03-15, Balance as of period end |
| 2021-12-31 | $31.34M | -77.9% | 2023-03-08, Balance as of period end |
| 2020-12-31 | $142.09M | n/m | 2022-03-09, Balance as of period end |
| 2019-12-31 | $11.97M | -77.0% | 2021-03-09, Balance as of period end |
| 2018-12-31 | $51.96M | n/a | 2020-03-12, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $296.68M | +33.3% |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | $570.12M | -16.3% |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $71.33M | -53.7% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | $93.03M | +58.9% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $93.68M | -30.9% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $93.89M | +10.9% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $679.57M | +51.1% |
| Insmed Inc (INSM) | 2025-12-31 | $510.44M | -8.0% |
| Opko Health, Inc. (OPK) | 2025-12-31 | $364.41M | -14.6% |
Compare MIRM, BBIO, HCM, TVTX side by side · Screen every company in Pharmaceutical Preparations ↗